Innovation Research
We're developing better more intelligent viral vectors to push science forward
Our approach to innovation is clear
1. Novel lentiviral and retroviral manufacturing technologies
Improving manufacturing yields and vector-specific performance
Engineered lentiviral and retroviral vector backbones for improved safety & efficacy
Novel suspension cell line development for lentiviral and retroviral GMP manufacturing
Developing a stable lentiviral packaging cell line
Novel media additives and transfection enhancers
2. Ligand-modified vectors
Physically engineered viral vectors to convey specific performance enhancing properties
Tissue specific tropism
Affinity purification and viral vector concentration
Transduction efficiency enhancement
3. Programmable intelligent vectors
Disruptive potential to establish new industry-standard viral vector platforms
Anti-oncogenic safety switches
Non-integrating lentiviral vectors for in vivo applications
Viral vectors with tissue-specific and cell-specific tropism and activity
“When developing vectors, we always have de-risking in the back of our minds.”
“We have several synergistic projects that include serum-free suspension cell lines for stable vector production.”